The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening

被引:2
作者
Xie, Hongyu [1 ,2 ,3 ]
Wei, Mingjing [1 ,4 ]
Yao, Lifang [4 ,5 ]
Liu, Yi [4 ,6 ]
Xie, Xing [1 ,4 ]
Li, Xiao [1 ,2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Womens Hosp, Zhejiang Prov Key Lab Precis Diag & Therapy Major, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Clin Res Ctr, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Canc Res Inst, Hangzhou, Peoples R China
[4] Zhejiang Univ, Womens Hosp, Dept Gynecol Oncol, Sch Med, Hangzhou, Zhejiang, Peoples R China
[5] Shaoxing Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Shaoxing, Zhejiang, Peoples R China
[6] Hangzhou Xixi Hosp, 2 Hengbu St, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical cancer; HPV receptor; single nucleotide polymorphisms; HPV susceptibility; cervical intraepithelial neoplasia; GROWTH-FACTOR RECEPTOR-2; ASSOCIATION; SUSCEPTIBILITY; PROTEOGLYCANS; POLYMORPHISMS; MECHANISMS; MUTATIONS; RISK; SNPS;
D O I
10.1128/spectrum.05117-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Virus receptors are known to mediate virus attachment and further lead to virus infection of the host cells. In the current study, we investigated the relationship between single nucleotide polymorphisms (SNPs) in human papillomavirus (HPV) receptor associated genes and HPV susceptibility and clinical outcomes in Chinese women, and to explore the new triaging strategy for non-16/18 high-risk HPV infection. To investigate the relationship between single nucleotide polymorphisms (SNPs) in human papillomavirus (HPV) receptor associated genes and HPV susceptibility and clinical outcomes in Chinese women, from October 2016 to March 2020, a total of 3,066 women were recruited for a 3-year prospective population-based cervical cancer screening clinical trial. The primary endpoint was histological cervical intraepithelial neoplasia 2 and worse (CIN2+). Twenty-nine SNPs of HPV receptor associated genes on women with available cytology residual samples at baseline were detected using MALDI-TOF MS. Eligible data were available for 2,938 women. Rs16894821 (GG versus AA, OR =1.71 [1.08 to 2.69]) and rs724236 (TT versus AA, OR = 1.73 [1.14 to 2.62]) in SDC2 were significantly related to the HPV susceptibility. And rs2575712 (TT versus GG, OR = 2.78 [1.22 to 6.36]) in SDC2 was associated with increased HPV 16/18 susceptibility. Four SNPs (rs1047057 and rs10510097 in FGFR2 gene, rs2575735 in SDC2 gene, and rs878949 in HSPG2 gene) were significantly associated with persistent HPV infection. Importantly, the genotypes of rs16894821 under recessive model (GG versus AA/AG, OR = 2.40 [1.12 to 5.15]) in SDC2 and rs11199993 under dominant model (GC/CC versus GG, OR = 1.64 [1.01 to 2.68]) in FGFR2 were significantly associated with the disease progression. Finally, SNPs showed comparable efficacy in detecting CIN2+ for the women infected with non-HPV16/18 compared with cervical cytology (sensitivity: 0.51 [0.36 to 0.66] versus 0.44 [0.30 to 0.60], specificity: 0.96 [0.96 to 0.97] versus 0.98 [0.97 to 0.99], positive predictive value: 0.23 [0.15 to 0.33] versus 0.33 [0.22 to 0.47], and negative predictive value: 0.99 [0.98 to 0.99] versus 0.99 [0.98 to 0.99]). SNPs in HPV receptor related genes may influence HPV susceptibilities and clinical outcomes in Chinese women.IMPORTANCE Virus receptors are known to mediate virus attachment and further lead to virus infection of the host cells. In the current study, we investigated the relationship between single nucleotide polymorphisms (SNPs) in human papillomavirus (HPV) receptor associated genes and HPV susceptibility and clinical outcomes in Chinese women, and to explore the new triaging strategy for non-16/18 high-risk HPV infection.
引用
收藏
页数:9
相关论文
共 44 条
[1]   Structural Variations of the 3D Genome Architecture in Cervical Cancer Development [J].
Adeel, Muhammad Muzammal ;
Jiang, Hao ;
Arega, Yibeltal ;
Cao, Kai ;
Lin, Da ;
Cao, Canhui ;
Cao, Gang ;
Wu, Peng ;
Li, Guoliang .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[2]  
Akerman GS, 2001, CANCER RES, V61, P3837
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   Integrated genomic and molecular characterization of cervical cancer [J].
Burk, Robert D. ;
Chen, Zigui ;
Saller, Charles ;
Tarvin, Katherine ;
Carvalho, Andre L. ;
Scapulatempo-Neto, Cristovam ;
Silveira, Henrique C. ;
Fregnani, Jose H. ;
Creighton, Chad J. ;
Anderson, Matthew L. ;
Castro, Patricia ;
Wang, Sophia S. ;
Yau, Christina ;
Benz, Christopher ;
Robertson, A. Gordon ;
Mungall, Karen ;
Lim, Lynette ;
Bowlby, Reanne ;
Sadeghi, Sara ;
Brooks, Denise ;
Sipahimalani, Payal ;
Mar, Richard ;
Ally, Adrian ;
Clarke, Amanda ;
Mungall, Andrew J. ;
Tam, Angela ;
Lee, Darlene ;
Chuah, Eric ;
Schein, Jacqueline E. ;
Tse, Kane ;
Kasaian, Katayoon ;
Ma, Yussanne ;
Marra, Marco A. ;
Mayo, Michael ;
Balasundaram, Miruna ;
Thiessen, Nina ;
Dhalla, Noreen ;
Carlsen, Rebecca ;
Moore, Richard A. ;
Holt, Robert A. ;
Jones, Steven J. M. ;
Wong, Tina ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Kucherlapati, Raju ;
Hadjipanayis, Angela ;
Seidman, Jonathan ;
Kucherlapati, Melanie ;
Ren, Xiaojia ;
Xu, Andrew W. .
NATURE, 2017, 543 (7645) :378-+
[5]   Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease [J].
Chanock, S .
DISEASE MARKERS, 2001, 17 (02) :89-98
[6]   Genome-wide Association Study of Susceptibility Loci for Cervical Cancer [J].
Chen, Dan ;
Juko-Pecirep, Ivana ;
Hammer, Joanna ;
Ivansson, Emma ;
Enroth, Stefan ;
Gustavsson, Inger ;
Feuk, Lars ;
Magnusson, Patrik K. E. ;
McKay, James D. ;
Wilander, Erik ;
Gyllensten, Ulf .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09) :624-633
[7]   Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients [J].
Choi, Chel Hun ;
Chung, Joon-Yong ;
Kim, Jae-Hoon ;
Kim, Byoung-Gie ;
Hewitt, Stephen M. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14 :1-12
[8]   Cervical cancer [J].
Cohen, Paul A. ;
Jhingran, Anjua ;
Oaknin, Ana ;
Denny, Lynette .
LANCET, 2019, 393 (10167) :169-182
[9]   Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer [J].
Cole, Claire ;
Lau, Sin ;
Backen, Alison ;
Clamp, Andrew ;
Rushton, Graham ;
Dive, Caroline ;
Hodgkinson, Cassandra ;
McVey, Rhona ;
Kitchener, Henry ;
Jayson, Gordon C. .
CANCER BIOLOGY & THERAPY, 2010, 10 (05) :495-504
[10]  
Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P674, DOI [10.1001/jama.2018.10897, 10.1097/01.ogx.0000549540.69362.81]